| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |